12-6936728-ACAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG-ACAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAG

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BA1

The NM_001940.4(ATN1):​c.1506_1508dupGCA​(p.Gln502dup) variant causes a disruptive inframe insertion change involving the alteration of a non-conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. H503H) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.14 ( 1640 hom., cov: 0)
Exomes 𝑓: 0.16 ( 4193 hom. )
Failed GnomAD Quality Control

Consequence

ATN1
NM_001940.4 disruptive_inframe_insertion

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: 0.621

Publications

8 publications found
Variant links:
Genes affected
ATN1 (HGNC:3033): (atrophin 1) Dentatorubral pallidoluysian atrophy (DRPLA) is a rare neurodegenerative disorder characterized by cerebellar ataxia, myoclonic epilepsy, choreoathetosis, and dementia. The disorder is related to the expansion from 7-35 copies to 49-93 copies of a trinucleotide repeat (CAG/CAA) within this gene. The encoded protein includes a serine repeat and a region of alternating acidic and basic amino acids, as well as the variable glutamine repeat. Alternative splicing results in two transcripts variants that encode the same protein. [provided by RefSeq, Jul 2016]
ATN1 Gene-Disease associations (from GenCC):
  • congenital hypotonia, epilepsy, developmental delay, and digital anomalies
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Illumina, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • dentatorubral-pallidoluysian atrophy
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 12-6936728-A-ACAG is Benign according to our data. Variant chr12-6936728-A-ACAG is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 599473.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.182 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ATN1NM_001940.4 linkc.1506_1508dupGCA p.Gln502dup disruptive_inframe_insertion Exon 5 of 10 ENST00000396684.3 NP_001931.2 P54259

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ATN1ENST00000396684.3 linkc.1506_1508dupGCA p.Gln502dup disruptive_inframe_insertion Exon 5 of 10 1 NM_001940.4 ENSP00000379915.2 P54259
ATN1ENST00000356654.8 linkc.1506_1508dupGCA p.Gln502dup disruptive_inframe_insertion Exon 5 of 10 1 ENSP00000349076.3 P54259

Frequencies

GnomAD3 genomes
AF:
0.136
AC:
19678
AN:
144842
Hom.:
1642
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.0420
Gnomad AMI
AF:
0.120
Gnomad AMR
AF:
0.123
Gnomad ASJ
AF:
0.170
Gnomad EAS
AF:
0.0550
Gnomad SAS
AF:
0.164
Gnomad FIN
AF:
0.209
Gnomad MID
AF:
0.152
Gnomad NFE
AF:
0.184
Gnomad OTH
AF:
0.129
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.162
AC:
231434
AN:
1431410
Hom.:
4193
Cov.:
0
AF XY:
0.162
AC XY:
115448
AN XY:
713010
show subpopulations
African (AFR)
AF:
0.0362
AC:
1165
AN:
32198
American (AMR)
AF:
0.0998
AC:
3999
AN:
40056
Ashkenazi Jewish (ASJ)
AF:
0.147
AC:
3775
AN:
25634
East Asian (EAS)
AF:
0.0520
AC:
1953
AN:
37522
South Asian (SAS)
AF:
0.157
AC:
13328
AN:
85006
European-Finnish (FIN)
AF:
0.177
AC:
9300
AN:
52412
Middle Eastern (MID)
AF:
0.100
AC:
573
AN:
5706
European-Non Finnish (NFE)
AF:
0.172
AC:
188638
AN:
1093704
Other (OTH)
AF:
0.147
AC:
8703
AN:
59172
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
11124
22248
33371
44495
55619
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7008
14016
21024
28032
35040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.136
AC:
19680
AN:
144942
Hom.:
1640
Cov.:
0
AF XY:
0.137
AC XY:
9632
AN XY:
70372
show subpopulations
African (AFR)
AF:
0.0419
AC:
1624
AN:
38726
American (AMR)
AF:
0.123
AC:
1705
AN:
13880
Ashkenazi Jewish (ASJ)
AF:
0.170
AC:
573
AN:
3374
East Asian (EAS)
AF:
0.0555
AC:
262
AN:
4718
South Asian (SAS)
AF:
0.164
AC:
725
AN:
4422
European-Finnish (FIN)
AF:
0.209
AC:
2103
AN:
10066
Middle Eastern (MID)
AF:
0.167
AC:
48
AN:
288
European-Non Finnish (NFE)
AF:
0.184
AC:
12281
AN:
66600
Other (OTH)
AF:
0.128
AC:
253
AN:
1982
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
721
1442
2163
2884
3605
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
220
440
660
880
1100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.143
Hom.:
123

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Benign:3
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Mar 20, 2017
Institute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Normal variation in repetative sequence -

Feb 16, 2025
Laboratory of Genetics, Children's Clinical University Hospital Latvia
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dentatorubral-pallidoluysian atrophy;C5193125:Congenital hypotonia, epilepsy, developmental delay, and digital anomalies Uncertain:1Benign:1
May 10, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 14, 2018
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

not provided Benign:2
May 19, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Congenital hypotonia, epilepsy, developmental delay, and digital anomalies Benign:1
Dec 12, 2023
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

- -

ATN1-related disorder Benign:1
Apr 11, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
0.62
Mutation Taster
=87/13
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs60216939; hg19: chr12-7045891; COSMIC: COSV63110246; COSMIC: COSV63110246; API